Henrik Zetterberg, M.D., Ph.D.

Professor of Neurochemistry, University of Gothenburg, Sweden and University College London, UK; Clinical Chemist, Sahlgrenska University Hospital, Gothenburg, Sweden


Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK, and a Clinical Chemist at Sahlgrenska University Hospital in Gothenburg, Sweden. He is Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg, leads the UK DRI Fluid Biomarker Laboratory at UCL, and is a Key Member of the Hong Kong Center for Neurodegenerative Diseases and a Visiting Professor in the UW Department of Medicine, School of Medicine and Public Health, Madison, Wisconsin. His main research focus and clinical interest are fluid biomarkers for brain diseases, neurodegenerative diseases in particular. He has published more than 1,800 scientific articles and received many awards.

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Palmqvist, S., Warmenhoven, N., Anastasi, F., Pilotto, A., Janelidze, S., Tideman, P., Stomrud, E., Mattsson-Carlgren, N., Smith, R., Ossenkoppele, R., Tan, K., Dittrich, A., Skoog, I., Zetterberg, H., … Hansson, O. Plasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform, Nature Medicine, April 9, 2025, Read More

Oh, H. S., Urey, D. Y., Karlsson, L., Zhu, Z., Shen, Y., ... Stevens, B., ... Zetterberg, H., ... Hansson, O., Cruchaga C., & Wyss-Coray, T. A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease, Nature Medicine, March 31, 2025, Read More

Labonte, J., Sugarman, M. A., Pettway, E., Zetterberg, H., Blennow, K., … Alosco, M. L. Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkers, Journal of Alzheimer's Disease, March 28, 2025, Read More

Odo, C. C., Strong, J., Lose, S. R., Ma, Y., Gallagher, C. L., Bendlin, B. B., Zetterberg, H., Blennow, K., Carlsson, C. M., Kollmorgen, G., Quijano-Rubio, C., Chin, N. A., Asthana, S., Johnson, S. C., Pontes Monteiro, J., & Okonkwo, O. C. Cardiovascular rate pressure product is associated with NfL in older adults at risk for AD, Alzheimer's & Dementia, March 25, 2025, Read More

Waury, K., Kvartsberg, H., Zetterberg, H., Blennow, K., Teunissen, C. E., & Abeln, S. Data-driven evaluation of suitable immunogens for improved antibody selection, Protein Science, March 21, 2025, Read More

Jauregi-Zinkunegi, A., Wilson, R. E., E Langhough, R., Ashton, N. J., Blennow, K., Johnson, S. C., Zetterberg, H., Bruno, D., & Mueller, K. D. Associations between the logical memory test story recall metrics and plasma biomarkers for Alzheimer’s disease in individuals free of dementia, The Clinical Neuropsychologist, March 20, 2025, Read More

Lantero-Rodriguez, J., Montoliu-Gaya, L., Ashton, N. J., Pola, I., Therriault, J., ... Zetterberg, H., … Benedet, A. L. Biofluid-based staging of Alzheimer’s disease, Acta Neuropathologica, March 17, 2025, Read More

Sanchez, E., Coughlan, G. T., Wilkinson, T., Ramirez, J., Mirza, S. S., ... Zetterberg, H., … ONDRI Investigators Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Disease, Neurology, March 10, 2025, Read More

Knorr, U., Simonsen, A. H., Nilsson, J., Brinkmalm, A., Zetterberg, H., Blennow, K., Knudsen, M. B., Forman, J., Miskowiak, K. W., Hasselbalch, S. G., & Kessing, L. V. Associations between cerebrospinal fluid synaptic protein biomarkers and cognitive function in bipolar disorder, Journal of Psychiatric Research, March 8, 2025, Read More

Alpaugh, M., Lantero-Rodriguez, J., Benedet, A. L., Manseau, U., Boutin, M., Maiuri, M., Denis, H. L., Masnata, M., Fazal, S. V., Chouinard, S., Rosa-Neto, P., Barker, R. A., Blennow, K., Zetterberg, H., Labib, R., & Cicchetti, F. Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity, Journal of Neurology, March 6, 2025, Read More

Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., La Joie, R., Rabinovici, G. D., Franzmeier, N., Johnson, K., Barkhof, F., Shaw, L. M., Arkhipenko, A., Schindler, S. E., Honig, L. S., Moscoso Rial, A., Schöll, M., Zetterberg, H., Blennow, K., Hansson, O., & Farrar, G. Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer’s disease, Alzheimer's & Dementia, March 5, 2025, Read More

Lennol, M. P., García-Ayllón, M. S., Avilés-Granados, C., Trasciatti, C., Tolassi, C., Quaresima, V., Arici, D., Cristillo, V., Volonghi, I., Caprioli, F., De Giuli, V., Mariotto, S., Ferrari, S., Zanusso, G., Ashton, N. J., Zetterberg, H., Blennow, K., Padovani, A., Pilotto, A., & Sáez-Valero, J. Increased cerebrospinal fluid ACE2 fragments as a read-out of brain infection in COVID-19 encephalopathy patients, The Journal of Infectious Diseases, February 26, 2025, Read More

Lennol, M. P., García-Ayllón, M. S., Avilés-Granados, C., Trasciatti, C., Tolassi, C., Quaresima, V., Arici, D., Cristillo, V., Volonghi, I., Caprioli, F., De Giuli, V., Mariotto, S., Ferrari, S., Zanusso, G., Ashton, N. J., Zetterberg, H., Blennow, K., Padovani, A., Pilotto, A., & Sáez-Valero, J. Increased cerebrospinal fluid ACE2 fragments as a read-out of brain infection in COVID-19 encephalopathy patients, The Journal of Infectious Diseases, February 26, 2025, Read More

Yakoub, Y., Gonzalez-Ortiz, F., Ashton, N. J., Déry, C., Strikwerda-Brown, C., St-Onge, F., Ourry, V., Schöll, M., Geddes, M. R., Ducharme, S., Montembeault, M., Rosa-Neto, P., Soucy, J. P., Breitner, J. C. S., Zetterberg, H., Blennow, K., Poirier, J., Villeneuve, S., & PREVENT−AD Research Group Plasma p‐tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10‐year window, Alzheimer's & Dementia, February 26, 2025, Read More

Anastasi, F., Fernández-Lebrero, A., Ashton, N. J., Ortiz-Romero, P., Torres-Torronteras, J., … Zetterberg, H., ... Suárez-Calvet, M. A head-to-head comparison of plasma biomarkers to detect Alzheimer’s disease in a memory clinic, Alzheimer's & Dementia, February 25, 2025, Read More

Dittrich, A., Blennow, K., Tan, K., Benedet, A. L., Skoog, I., Höglund, K., Ashton, N. J., Zetterberg, H., & Kern, S. Evaluation of two plasma-based proteotyping assays against APOE ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies, Alzheimer's & Dementia, February 23, 2025, Read More

Karlsson, L., Vogel, J., Arvidsson, I., Åström, K., Strandberg, O., Seidlitz, J., Bethlehem, R. A. I., Stomrud, E., Ossenkoppele, R., Ashton, N. J., Zetterberg, H., Blennow, K., Palmqvist, S., Smith, R., Janelidze, S., La Joie, R., Rabinovici, G. D., Binette, A. P., Mattsson-Carlgren, N., & Hansson, O. Machine learning prediction of tau-PET in Alzheimer’s disease using plasma, MRI, and clinical data, Alzheimer's & Dementia, February 22, 2025, Read More

Arslan, B., Brum, W. S., Pola, I., Therriault, J., Rahmouni, N., Stevenson, J., Servaes, S., Tan, K., Vitali, P., Montembeault, M., Klostranec, J., Macedo, A. C., Tissot, C., Gauthier, S., Lantero-Rodriguez, J., Zimmer, E. R., Blennow, K., Zetterberg, H., … Ashton, N. J. The impact of kidney function on Alzheimer’s disease blood biomarkers: implications for predicting amyloid-β positivity, Alzheimer's Research & Therapy, February 19, 2025, Read More

Boccalini, C., Peretti, D. E., Scheffler, M., Mu, L., Griffa, A., Testart, N., Allali, G., Prior, J. O., Ashton, N. J., Zetterberg, H., Blennow, K., Frisoni, G. B., & Garibotto, V. Sex differences in the association of Alzheimer’s disease biomarkers and cognition in a multicenter memory clinic study, Alzheimer's Research & Therapy, February 18, 2025, Read More

Yun, J., Shin, D., Lee, E. H., Kim, J. P., Ham, H., Gu, Y., Chun, M. Y., Kang, S. H., Kim, H. J., Na, D. L., Kim, C. H., Kim, K. W., Kim, S. E., Kim, Y., Kim, J., Jung, N. Y., Kim, Y. J., Cho, S. H., Zetterberg, H., Blennow, K., … ADNI, TRIAD, and K-ROAD study groups Temporal Dynamics and Biological Variability of Alzheimer Biomarkers, JAMA Neurology, February 17, 2025, Read More

Agmon, G., Cho, S., Ash, S., Cousins, K. A. Q., Blennow, K., Zetterberg, H., … Nevler, N. Automatic quantification of syntactic complexity in natural spontaneous speech of people with primary progressive aphasia, Aphasiology, February 17, 2025, Read More

Nordvall, G., Yan, P., Agholme, L., Lundkvist, J., Sandin, J., Biverstål, H., Winblad, B., Zetterberg, H., Klintenberg, R., Ferm, M., Cirrito, J. R., & Lee, J. M. γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 mice, The Journal of Pharmacology and Experimental Therapeutics, February 15, 2025, Read More

Delaby, C., Alcolea, D., Busto, G., Gabelle, A., Ayrignac, X., Bennys, K., Muiño, E., Villatoro, P., Fernández-Cadenas, I., Pradeilles, N., Bounasri, S. E., Torres, S., Hirtz, C., Zetterberg, H., Lleó, A., Fortea, J., & Lehmann, S. Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia, Alzheimer's Research & Therapy, February 13, 2025, Read More

Cotelli, M. S., Tarantino, B., Tan, K., Huber, H., Cantoni, V., Bracca, V., Gasparotti, R., Premi, E., Logroscino, G., Benedet, A. L., Blennow, K., Zetterberg, H., Grassi, M., Ashton, N. J., & Borroni, B. Predicting survival rate by plasma biomarkers and clinical variables in syndromes associated with frontotemporal lobar degeneration, Alzheimer's & Dementia, February 12, 2025, Read More

Andersson, E., Lindblom, N., Janelidze, S., Salvadó, G., Gkanatsiou, E., Söderberg, L., Möller, C., Lannfelt, L., Ge, J., Hanrieder, J., Blennow, K., Deierborg, T., Mattsson-Carlgren, N., Zetterberg, H., Gouras, G., & Hansson, O. Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice, Nature Aging, February 12, 2025, Read More

Koivikko, P., Katila, A. J., Takala, R. S., Hossain, I., Luoto, T. M., Raj, R., Koivisto, M., Tenovuo, O., Blennow, K., Hutchinson, P., Maanpää, H. R., Mohammadian, M., Newcombe, V. F., Sanchez, J. C., Tallus, J., van Gils, M., Zetterberg, H., & Posti, J. P. Blood biomarkers to identify patients with different intracranial lesion combinations after traumatic brain injury, Brain and Spine, February 8, 2025, Read More

Wolner, S. H., Gleerup, H. S., Musaeus, C. S., Høgh, P., Ashton, N. J., Brinkmalm, A., Nilsson, J., Grötschel, L., Zetterberg, H., Blennow, K., Hasselbalch, S. G., Walls, A. B., & Simonsen, A. H. Synaptosomal-Associated Protein 25 kDA (SNAP-25) Levels in Cerebrospinal Fluid: Implications for Alzheimer’s Disease Diagnosis and Monitoring, Synapse, February 6, 2025, Read More

Sogorb-Esteve, A., Weiner, S., Simrén, J., Swift, I. J., Bocchetta, M., ... Zetterberg, H., … GENFI Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes, Science Translational Medicine, February 5, 2025, Read More

Carrol, D., Busse, W. W., Frye, C. J., Klaus, D. R., Bach, J. C., Floerke, H., Bendlin, B. B., Zetterberg, H., Blennow, K., Heslegrave, A., Hoel, R., & Rosenkranz, M. A. Regional brain structural alterations in reward and salience networks in asthma, Brain, Behavior, and Immunity, February 5, 2025, Read More

Jang, H., Shin, D., Yoo, H., Zetterberg, H., Blennow, K., … K‐ROAD study groups Differential roles of Alzheimer’s disease plasma biomarkers in stepwise biomarker-guided diagnostics, Alzheimer's & Dementia, February 5, 2025, Read More

Ashton, N. J., Keshavan, A., Brum, W. S., Andreasson, U., Arslan, B., … Hansson, O., ... Shaw, L. M., ... Zetterberg, H. The Alzheimer’s Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study, Alzheimer's & Dementia, February 5, 2025, Read More

Di Molfetta, G., Pola, I., Tan, K., Isaacson, R., Blennow, K., Ashton, N. J., Benedet, A. L., & Zetterberg, H. Inflammation biomarkers and Alzheimer’s disease: A pilot study using NULISAseq, Alzheimer's & Dementia, January 30, 2025, Read More

Duff, E. P., Zetterberg, H., Heslegrave, A., Dehghan, A., Elliott, P., Allen, N., Runz, H., Laban, R., Veleva, E., Whelan, C. D., Sun, B. B., & Matthews, P. M. Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection, Nature Medicine, January 30, 2025, Read More

Johnsson, M., Eriksson, K., Rosenstein, I., Novakova, L., Malmeström, C., Lycke, J., Sandgren, S., Zetterberg, H., Blennow, K., Johansson, K., & Axelsson, M. The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use, Multiple Sclerosis and Related Disorders, January 29, 2025, Read More

McKeever, A., Swann, P., Malpetti, M., Donaghy, P. C., Thomas, A., Mak, E., Carter, S. F., Tan, J. H. K., Hong, Y. T., Fryer, T. D., Heslegrave, A., Zetterberg, H., Su, L., Chouliaras, L., Rowe, J. B., & O'Brien, J. T. Polygenic risk discriminates Lewy body dementia from Alzheimer’s disease, Alzheimer's & Dementia, January 24, 2025, Read More

Oomens, J. E., van Gils, V., Vos, S. J. B., Freeze, W. M., Maserejian, N. N., ... Zetterberg, H., ... Ossenkoppele, R., … BIOFACE Study Group Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study, JAMA Network Open, January 22, 2025, Read More

Clemmensen, F. K., Gramkow, M. H., Simonsen, A. H., Ashton, N. J., Huber, H., Blennow, K., Zetterberg, H., Waldemar, G., Hasselbalch, S. G., & Frederiksen, K. S. Short-term variability of Alzheimer’s disease plasma biomarkers in a mixed memory clinic cohort, Alzheimer's Research & Therapy, January 21, 2025, Read More

Ao, J., Picard, C., Auld, D., Zetterberg, H., Brinkmalm, A., Blennow, K., Villeneuve, S., Breitner, J. C. S., Poirier, J., & PREVENT-AD research group Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease, Molecular Psychiatry, January 18, 2025, Read More

Gleerup, H. S., Simonsen, A. H., Grötschel, L., Gramkow, M. H., Høgh, P., Blennow, K., Zetterberg, H., Ashton, N., & Hasselbalch, S. G. Plasma biomarkers of amyloid, tau, astrogliosis, and axonal injury in a mixed memory clinic cohort, Alzheimer's & Dementia, January 16, 2025, Read More

Ng, B., & Zetterberg, H. Know your brain aging to know your resilience in neurodegenerative diseases, Brain Communications, January 15, 2025, Read More

Pretkalnina, D., Kenina, E., Gailite, L., Rots, D., Blennow, K., Zetterberg, H., & Kenina, V. Evaluating plasma biomarkers NfL, GFAP, GDF15, and FGF21 as indicators of disease severity in Charcot–Marie Tooth patients, Frontiers in Neurology, January 14, 2025, Read More

Andersson, K., Akel, S., Asztély, F., Larsson, D., Zetterberg, H., & Zelano, J. Higher plasma total tau concentrations among patients reporting CNS-related side effects from antiseizure medication, Seizure, January 12, 2025, Read More

Benussi, A., Huber, H., Tan, K., Cantoni, V., Rivolta, J., Cotelli, M. S., Benedet, A. L., Blennow, K., Zetterberg, H., Ashton, N. J., & Borroni, B. Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer’s disease from syndromes associated with frontotemporal lobar degeneration, Alzheimer's & Dementia, January 8, 2025, Read More

Ashton, N. J., & Zetterberg, H. A blood test for Alzheimer’s disease: a decade of progress and success, eBioMedicine, January 7, 2025, Read More

Wang, Y. T., Ashton, N. J., Therriault, J., Benedet, A. L., … Zetterberg, H., Rosa-Neto, P. Identify biological Alzheimer’s disease using a novel nucleic acid–linked protein immunoassay, Brain Communications, January 7, 2025, Read More

Rydén, L., Seidu, N. M., Wetterberg, H., Najar, J., Waern, M., Kern, S., Blennow, K., Zetterberg, H., Skoog, I., & Zettergren, A. Polygenic risk scores for atrial fibrillation and heart failure and the risk of stroke and dementia, Brain Communications, January 7, 2025, Read More

Van Egroo, M., Beckers, E., Ashton, N. J., Blennow, K., Zetterberg, H., & Jacobs, H. I. L. Sex differences in the relationships between 24-h rest-activity patterns and plasma markers of Alzheimer’s disease pathology, Alzheimer's Research & Therapy, December 30, 2024, Read More

Gibson, L. L., Gonzalez, M. C., Ashton, N. J., Tovar-Rios, D., Blanc, F., Pilotto, A., Lemstra, A., Paquet, C., Ballard, C., Zetterberg, H., Aarsland, D., & European–Dementia With Lewy Bodies (E‐DLB) Consortium Plasma phosphorylated tau and neuropsychiatric symptoms in dementia with Lewy bodies, Alzheimer's & Dementia, December 28, 2024, Read More

Watamura, N., Foiani, M. S., Bez, S., Bourdenx, M., Santambrogio, A., Frodsham, C., Camporesi, E., Brinkmalm, G., Zetterberg, H., , … Duff, K. E., Saido, T. C. In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds, Nature Neuroscience, December 24, 2024, Read More

Hazan, J., Abel, E., Rosa Grilo, M., Alawode, D., Laranjinha, I., Heslegrave, A. J., Liu, K. Y., Schott, J. M., Howard, R., Zetterberg, H., & Fox, N. C. How well do plasma Alzheimer’s disease biomarkers reflect the CSF amyloid status?, Journal of Neurology, Neurosurgery, and Psychiatry, December 18, 2024, Read More

Rosenstein, I., Novakova, L., Kvartsberg, H., Nordin, A., Rasch, S., Rembeza, E., Sandgren, S., Malmeström, C., Fruhwürth, S., Axelsson, M., Blennow, K., Zetterberg, H., & Lycke, J. Tyro3 and Gas6 are associated with white matter and myelin integrity in multiple sclerosis, Journal of Neuroinflammation, December 13, 2024, Read More

Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., ... Cruchaga, C., ... Glass C. K., ... Butovsky, O., ... Grutzendler, J., … Baker, D. J., Liddelow, S. A., ... Kipnis, J., ... Colonna, M., ... Riechers, S. P. Neuroinflammation in Alzheimer disease, Nature Reviews Immunology, December 9, 2024, Read More

Perellón-Alfonso, R., Abellaneda-Pérez, K., Pileckyte, I., Cabello-Toscano, M., Mulet-Pons, L., Vaqué-Alcázar, L., Cattaneo, G., Redondo-Camós, M., España-Irla, G., Delgado-Gallen, S., Sánchez, J. S., Zetterberg, H., Tormos, J. M., Franzmeier, N., Pascual-Leone, A., & Bartrés-Faz, D. Spontaneous and perturbation-based EEG cortical excitability markers are associated with plasma p-tau181 concentration in healthy middle-aged adults, Heliyon, December 9, 2024, Read More

Ma, Y., Farris, C. M., Weber, S., Schade, S., Nguyen, H., Pérez-Soriano, A., Giraldo, D. M., Fernández, M., Soto, M., Cámara, A., Painous, C., Muñoz, E., Valldeoriola, F., Martí, M. J., Clarimon, J., Kallunki, P., Ma, T. C., Alcalay, R. N., Gomes, B. F., Blennow, K., Zetterberg, H., … Concha-Marambio, L. Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study, The Lancet, Neurology, December 1, 2024, Read More

Huber, H., Cantoni, V., Altomare, D., Grötschel, L., Montoliu-Gaya, L., Meda, F., Kvartsberg, H., Libri, I., Cotelli, M. S., Zetterberg, H., Blennow, K., Borroni, B., & Ashton, N. J. The detection of GRN mutation carriers by progranulin blood protein levels from finger-stick collection, Alzheimer's & Dementia, November 30, 2024, Read More

Joynes, C. M., Bilgel, M., An, Y., Moghekar, A. R., Ashton, N. J., Kac, P. R., Karikari, T. K., Blennow, K., Zetterberg, H., Thambisetty, M., Ferrucci, L., Resnick, S. M., & Walker, K. A. Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset, Alzheimer's & Dementia, November 28, 2024, Read More

Fernandes Gomes, B., Kumar, A., Ashton, N. J., Hall, S., Stomrud, E., Smith, R., Zetterberg, H., Blennow, K., Mattsson-Carlgren, N., & Hansson, O. Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders, Brain Communications, November 19, 2024, Read More

1. Rea Reyes, R. E., Cody, K. A., Wilson, R. E., Zetterberg, H., Chin, N. A., Jonaitis, E. M., Bahr, M., Mandel, O., Wintlend, M., Bendlin, B. B., Okonkwo, O. C., Clark, L. R., Zammit, M., Asthana, S., Christian, B. T., Betthauser, T. J., Eisenmenger, L., Langhough, R. E., & Johnson, S. C. Visual read of [F-18]florquinitau PET that includes and extends beyond the mesial temporal lobe is associated with increased plasma pTau217 and cognitive decline in a cohort that is enriched with risk for Alzheimer’s disease, Alzheimer's & Dementia, November 19, 2024, Read More

Simrén, J., Ashton, N. J., Suárez-Calvet, M., & Zetterberg, H. Alzheimer’s disease—Biomarkers, clinical evaluation or both?, Journal of Neuropsychology, November 14, 2024, Read More

2. Therriault, J., Janelidze, S., Benedet, A. L., Ashton, N. J., Arranz Martínez, J., Gonzalez-Escalante, A., Bellaver, B., Alcolea, D., Vrillon, A., Karim, H., Mielke, M. M., … Petersen, R. C., … Zetterberg, H., … Hansson, O., & Rosa-Neto, P. Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability, Nature Aging, November 12, 2024, Read More

Woo, M. S., Therriault, J., Jonaitis, E. M., Wilson, R., Langhough, R. E., Rahmouni, N., Benedet, A. L., Ashton, N. J., Tissot, C., Lantero-Rodriguez, J., Macedo, A. C., Servaes, S., Wang, Y. T., Arias, J. F., Hosseini, S. A., Betthauser, T. J., Lussier, F. Z., Hopewell, R., Triana-Baltzer, G., Kolb, H. C., … Rosa-Neto, P. Identification of late-stage tau accumulation using plasma phospho-tau217, eBioMedicine, November 4, 2024, Read More

Safransky, M., Groh, J. R., Blennow, K., Zetterberg, H., Tripodis, Y., Martin, B., Weller, J., Asken, B. M., Rabinovici, G. D., Qiu, W. W. Q., McKee, A. C., Stein, T. D., Mez, J., Henson, R. L., Long, J., Morris, J. C., Perrin, R. J., Schindler, S. E., & Alosco, M. L. Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer Disease, Neurology, November 4, 2024, Read More

Olofsson, J., Bergström, S., Mravinacová, S., Kläppe, U., Öijerstedt, L., Zetterberg, H., Blennow, K., Ingre, C., Nilsson, P., & Månberg, A. Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, November 2, 2024, Read More

Aye, S., Frisell, O., Zetterberg, H., Skillbäck, T. B., Kern, S., Eriksdotter, M., Aho, E., Xia, X., Winblad, B., Wimo, A., & Jönsson, L. Costs of Care in Relation to Alzheimer’s Disease Severity in Sweden: A National Registry-Based Cohort Study, PharmacoEconomics, November 1, 2024, Read More

Warmenhoven, N., Salvadó, G., Janelidze, S., Mattsson-Carlgren, N., Bali, D., Orduña Dolado, A., Kolb, H., Triana-Baltzer, G., Barthélemy, N. R., Schindler, S. E., Aschenbrenner, A. J., Raji, C. A., Benzinger, T. L. S., Morris, J. C., Ibanez, L., Timsina, J., Cruchaga, C., Bateman, R. J., Ashton, N., Arslan, B., … Hansson, O. A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker Tests, Brain, October 28, 2024, Read More

Al-Diwani, A., Provine, N. M., Murchison, A., Laban, R., Swann, O. J., Koychev, I., Sheerin, F., Da Mesquita, S., Heslegrave, A., Zetterberg, H., Klenerman, P., & Irani, S. R. Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodes, Brain, October 21, 2024, Read More

Götze, K., Vrillon, A., Dumurgier, J., Indart, S., Sanchez-Ortiz, M., Slimi, H., Raynaud-Simon, A., Cognat, E., Martinet, M., Zetterberg, H., Blennow, K., Hourrègue, C., Bouaziz-Amar, E., Paquet, C., & Lilamand, M. Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study, Alzheimer's Research & Therapy, October 19, 2024, Read More

Miner, A. E., Groh, J. R., Tripodis, Y., Adler, C. H., Balcer, L. J., Bernick, C., Zetterberg, H., Blennow, K., Peskind, E., Ashton, N. J., Gaudet, C. E., Martin, B., Palmisano, J. N., Banks, S. J., Barr, W. B., Wethe, J. V., Cantu, R. C., Dodick, D. W., Katz, D. I., Mez, J., … DIAGNOSE CTE Research Project Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players, Alzheimer's & Dementia, October 1, 2024, Read More

Johansson, C., Thordardottir, S., Laffita-Mesa, J., Pannee, J., Rodriguez-Vieitez, E., Zetterberg, H., Blennow, K., & Graff, C. Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease, Alzheimer's Research & Therapy, September 25, 2024, Read More

Leuzy, A., Heeman, F., Bosch, I., Lenér, F., Dottori, M., Quitz, K., Moscoso, A., Kern, S., Zetterberg, H., Blennow, K., & Schöll, M. REAL AD—Validation of a realistic screening approach for early Alzheimer’s disease, Alzheimer's & Dementia, September 23, 2024, Read More

Sandgren, S., Novakova, L., Nordin, A., Sabir, H., Axelsson, M., Malmeström, C., Zetterberg, H., & Lycke, J. The effect of alemtuzumab on neurodegeneration in relapsing-remitting multiple sclerosis: A five-year prospective mono-center study, Multiple Sclerosis and Related Disorders, September 13, 2024, Read More

Borda, M. G., Barreto, G. E., Baldera, J. P., de Lucia, C., Khalifa, K., Bergland, A. K., Pola, I., Botero-Rodríguez, F., Siow, R. C., Kivipelto, M., Zetterberg, H., Ashton, N. J., Ballard, C., Aarsland, D., & NJ FINGER A randomized, placebo-controlled trial of purified anthocyanins on cognitive function in individuals at elevated risk for dementia: Analysis of inflammatory biomarkers toward personalized interventions, Experimental Gerontology, September 9, 2024, Read More

Li, Y., Luo, L., Senicar, L., Asrosa, R., Kizilates, B., Xing, K., Torres, E., Xu, L., Li, D., Graham, N., Heslegrave, A., Zetterberg, H., Sharp, D. J., & Li, B. An Ultrasensitive Molecularly Imprinted Point-Of-Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein, Advanced Healthcare Materials, September 2, 2024, Read More

Koetsier, J., Cavill, R., Reijnders, R., Harvey, J., Homann, J., … Dobricic, V., … Scheltens, P., … Zetterberg, H., … Lill, C. L., Bertram, L., … Pishva, E. Blood-based multivariate methylation risk score for cognitive impairment and dementia, Alzheimer's & Dementia, August 28, 2024, Read More

Quaresima, V., Pilotto, A., Trasciatti, C., Tolassi, C., Parigi, M., Bertoli, D., Mordenti, C., Galli, A., Rizzardi, A., Caratozzolo, S., Benussi, A., Ashton, N. J., Blennow, K., Zetterberg, H., Giliani, S., Brugnoni, D., & Padovani, A. Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA, Neurology of Aging, August 28, 2024, Read More

Quaresima, V., Pilotto, A., Trasciatti, C., Tolassi, C., Parigi, M., Bertoli, D., Mordenti, C., Galli, A., Rizzardi, A., Caratozzolo, S., Benussi, A., Ashton, N. J., Blennow, K., Zetterberg, H., Giliani, S., Brugnoni, D., & Padovani, A. Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA, Neurobiology of Aging, August 22, 2024, Read More

Di Filippo, M., Gaetani, L., Centonze, D., Hegen, H., Kuhle, J., Teunissen, C. E., Tintoré, M., Villar, L. M., Willemse, E. A. J., Zetterberg, H., & Parnetti, L. Fluid biomarkers in multiple sclerosis: from current to future applications, The Lancet Regional Health Europe, August 22, 2024, Read More

Malpetti, M., Swann, P., Tsvetanov, K. A., Chouliaras, L., Strauss, A., Chikaura, T., Murley, A. G., Ashton, N. J., Barker, P., Jones, P. S., Fryer, T. D., Hong, Y. T., Cope, T. E., Savulich, G., Street, D., Bevan-Jones, W. R., Rittman, T., Blennow, K., Zetterberg, H., Aigbirhio, F. I., … Rowe, J. B. Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration, Brain, August 19, 2024, Read More

Zhang, Z., Xue, P., Bendlin, B. B., Zetterberg, H., De Felice, F., Tan, X., & Benedict, C. Melatonin: A potential nighttime guardian against Alzheimer’s, Molecular Psychiatry, August 11, 2024, Read More

Emeršič, A., Karikari, T. K., Kac, P. R., Gonzalez-Ortiz, F., Dulewicz, M., Ashton, N. J., Brecl Jakob, G., Horvat Ledinek, A., Hanrieder, J., Zetterberg, H., Rot, U., Čučnik, S., & Blennow, K. Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis, Multiple sclerosis and related disorders, August 5, 2024, Read More

Ivanova, K., Zolovs, M., Blennow, K., Zetterberg, H., Kurjāne, N., & Ķēniņa, V. Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers, Frontiers in Medicine, August 1, 2024, Read More

Fernström, E., Jarfelt, M., Blomstrand, M., Lannering, B., Axelsson, M., Wasling, P., Björk-Eriksson, T., Zetterberg, H., & Kalm, M. CSF biomarkers of neurotoxicity in childhood cancer survivors after cranial radiotherapy or surgery, Annals of Clinical and Translational Neurology, July 19, 2024, Read More

Lantero-Rodriguez, J., Camporesi, E., Montoliu-Gaya, L., Gobom, J., Piotrowska, D., Olsson, M., Burmann, I. M., Becker, B., Brinkmalm, A., Burmann, B. M., Perkinton, M., Ashton, N. J., Fox, N. C., Lashley, T., Zetterberg, H., Blennow, K., & Brinkmalm, G. Tau protein profiling in tauopathies: a human brain study, Molecular Neurodegeneration, July 19, 2024, Read More

Kasri, A., Camporesi, E., Gkanatsiou, E., Boluda, S., Brinkmalm, G., Stimmer, L., Ge, J., Hanrieder, J., Villain, N., Duyckaerts, C., Vermeiren, Y., Pape, S. E., Nicolas, G., Laquerrière, A., De Deyn, P. P., Wallon, D., Blennow, K., Strydom, A., Zetterberg, H., & Potier, M. C. Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome, Acta Neuropathologica, July 18, 2024, Read More

Doroszkiewicz, J., Kulczyńska-Przybik, A., Dulewicz, M., Mroczko, J., Borawska, R., Słowik, A., Zetterberg, H., Hanrieder, J., Blennow, K., & Mroczko, B. Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease, International Journal of Molecular Sciences, July 9, 2024, Read More

Delvenne, A., Gobom, J., Schindler, S. E., Kate, M. T., Reus, L. M., Dobricic, V., Tijms, B. M., Benzinger, T. L. S., Cruchaga, C., ... Bertram, L., … Zetterberg, H., ... Vos, S. J. B. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer’s disease, Alzheimer's & Dementia, July 6, 2024, Read More

Zarkali, A., Thomas, G. E. C., Zetterberg, H., & Weil, R. S. Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions, Nature Communications, July 5, 2024, Read More

Du, L., Langhough, R. E., Wilson, R. E., Reyes, R. E. R., Hermann, B. P., Jonaitis, E. M., Betthauser, T. J., Chin, N. A., Christian, B., Chaby, L., Jeromin, A., Molfetta, G. D., Brum, W. S., Arslan, B., Ashton, N., Blennow, K., Zetterberg, H., & Johnson, S. C. Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer’s risk-enhanced sample, Alzheimer's & Dementia, July 5, 2024, Read More

Andriuta, D., Ottoy, J., Ruthirakuhan, M., Feliciano, G., Dilliott, A. A., … Zetterberg, H., ... ONDRI Investigators Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases, Alzheimer's & Dementia, July 4, 2024, Read More

Peretti, D. E., Boccalini, C., Ribaldi, F., Scheffler, M., Marizzoni, M., Ashton, N. J., Zetterberg, H., Blennow, K., Frisoni, G. B., & Garibotto, V. Association of glial fibrillary acid protein, Alzheimer’s disease pathology and cognitive decline, Brain, June 28, 2024, Read More

Orduña Dolado, A., Stomrud, E., Ashton, N. J., Nilsson, J., Quijano-Rubio, C., Jethwa, A., Brum, W. S., Brinkmalm Westman, A., Zetterberg, H., Blennow, K., Janelidze, S., & Hansson, O. Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers, Alzheimer's Research & Therapy, June 22, 2024, Read More

Beckers, E., Van Egroo, M., Ashton, N. J., Blennow, K., Vandewalle, G., Zetterberg, H., Poser, B. A., & Jacobs, H. I. L. Microstructural associations between locus coeruleus, cortical, and subcortical regions are modulated by astrocyte reactivity: a 7T MRI adult lifespan study, Cerebral Cortex, 6/21/2024, Read More

Princen, K., Van Dooren, T., van Gorsel, M., Louros, N., Yang, X., … Zetterberg, H., ... Griffioen, G. Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer’s disease, Science, May 31, 2024, Read More

De Meyer, S., Schaeverbeke, J. M., Luckett, E. S., Reinartz, M., Blujdea, E. R., Cleynen, I., Dupont, P., Van Laere, K., Vanbrabant, J., Stoops, E., Vanmechelen, E., di Molfetta, G., Zetterberg, H., Ashton, N. J., Teunissen, C. E., Poesen, K., & Vandenberghe, R. Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET, Brain Communications, May 23, 2024, Read More

Jacobs, T., Jacobson, S. R., Fortea, J., Berger, J. S., Vedvyas, A., Marsh, K., He, T., Gutierrez-Jimenez, E., Fillmore, N. R., Gonzalez, M., Figueredo, L., Gaggi, N. L., Plaska, C. R., Pomara, N., Blessing, E., Betensky, R., Rusinek, H., Zetterberg, H., Blennow, K., Glodzik, L., … Alzheimer’s Disease Neuroimaging Initiative The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people, Immunity & Ageing, May 17, 2024, Read More

Rolandsson, O., Tornevi, A., Steneberg, P., Edlund, H., Olsson, T., Andreasson, U., Zetterberg, H., & Blennow, K. Acute Hyperglycemia Induced by Hyperglycemic Clamp Affects Plasma Amyloid-β in Type 2 Diabetes, Journal of Alzheimer's Disease, May 10, 2024, Read More

Gard, A., Kornaropoulos, E. N., Portonova Wernersson, M., Rorsman, I., Blennow, K., Zetterberg, H., Tegner, Y., De Maio, A., Markenroth Bloch, K., Björkman-Burtscher, I., Pessah-Rasmussen, H., Nilsson, M., & Marklund, N. Widespread White Matter Abnormalities in Concussed Athletes Detected by 7T Diffusion Magnetic Resonance Imaging, Journal of Neurotrauma, May 3, 2024, Read More

Gadd, G., Åberg, D., Wall, A., Zetterberg, H., Blennow, K., Jood, K., Jern, C., Isgaard, J., Svensson, J., & Åberg, N. D. A Nonlinear Relation between Body Mass Index and Long-Term Poststroke Functional Outcome-The Importance of Insulin Resistance, Inflammation, and Insulin-like Growth Factor-Binding Protein-1, International Journal of Molecular Sciences, April 30, 2024, Read More

Gadd, G., Åberg, D., Wall, A., Zetterberg, H., Blennow, K., Jood, K., Jern, C., Isgaard, J., Svensson, J., & Åberg, N. D. Nonlinear Relation between Body Mass Index and Long-Term Poststroke Functional Outcome-The Importance of Insulin Resistance, Inflammation, and Insulin-like Growth Factor-Binding Protein-1, International Journal of Molecular Sciences, April 30, 2024, Read More

Fruhwürth, S., Zetterberg, H., & Paludan, S. R. Microglia and amyloid plaque formation in Alzheimer’s disease – Evidence, possible mechanisms, and future challenges, Journal of Neuroinflammation, April 4, 2024, Read More

Brum, W. S., Cullen, N. C., Therriault, J., Janelidze, S., Rahmouni, N., Stevenson, J., Servaes, S., Benedet, A. L., Zimmer, E. R., Stomrud, E., Palmqvist, S., Zetterberg, H., Frisoni, G. B., Ashton, N. J., Blennow, K., Mattsson-Carlgren, N., Rosa-Neto, P., & Hansson, O. A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings, Nature Communications, March 14, 2024, Read More

Johnsson, M., Stenberg, Y. T., Farman, H. H., Blennow, K., Zetterberg, H., Malmeström, C., Sandgren, S., Rosenstein, I., Lycke, J., Axelsson, M., & Novakova, L. Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study, Multiple Sclerosis, March 13, 2024, Read More

Nilsson, J., Pichet Binette, A., Palmqvist, S., Brum, W. S., Janelidze, S., Ashton, N. J., Spotorno, N., Stomrud, E., Gobom, J., Zetterberg, H., Brinkmalm, A., Blennow, K., & Hansson, O. Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases, Brain, February 7, 2024, Read More

Homann, J., Osburg, T., Ohlei, O., Dobricic, V., Deecke, L., Bos, I., Vandenberghe, R., Gabel, S., Scheltens, P., Teunissen, C. E., Engelborghs, S., Frisoni, G., Blin, O., Richardson, J. C., Bordet, R., Lleó, A., Alcolea, D., Popp, J., Clark, C., Peyratout, G., Martinez-Lage, P., Tainta, M., Dobson, R.J.B., Legido-Quigley, C., Sleegers, K., Van Broeckhoven, C., Wittig, M., Franke, A., Lill, C.M., Blennow, K., Zetterberg, H., Lovestone, S., Streffer, J., Kate, M., Vos, S. J. B., Barkhof, F., Visser, P. J., & Bertram, L. Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset, Frontiers in Aging Neuroscience, March 21, 2022, Read More

Van Egroo, M., Riphagen, J. M., Ashton, N. J., Janelidze, S., Sperling, R. A., Johnson, K. A., Yang, H. S., Bennett, D. A., Blennow, K., Hansson, O., Zetterberg, H., & Jacobs, H. I. L. Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau, Molecular Psychiatry, April 5, 2023, Read More

Hansson, O., Blennow, K., Zetterberg, H., & Dage, J. Blood biomarkers for Alzheimer’s disease in clinical practice and trials, Nature Aging, May 18, 2023, Read More

Suárez-Calvet, M., Kleinberger, G., Araque Caballero, M. Á., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleó, A., Blesa, R., Gispert, J. D., Sánchez-Valle, R., Antonell, A., Rami, L., Molinuevo, J. L., Brosseron, F., Traschütz, A., Heneka, M. T., Struyfs, H., Engelborghs, S., Sleegers, K., Van Broeckhove, C., Zetterberg, H., Nellgard, B., Blennow, K., Crispin, A., Ewers, M., & Haass, C. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer’s disease and associate with neuronal injury markers, EMBO Molecular Medicine, March 3, 2016, Read More

Michno, W., Stringer, K. M., Enzlein, T., Passarelli, M. K., Escrig, S., Vitanova, K., Wood, J., Blennow, K., Zetterberg, H., Meibom, A., Hopf, C., Edwards, F. A., & Hanrieder, J. Following spatial Aβ aggregation dynamics in evolving Alzheimer’s disease pathology by imaging stable isotope labeling kinetics, Science Advances, June 16, 2021, Read More

Wilson, D. M., 3rd, Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. Hallmarks of neurodegenerative diseases, Cell, February 16, 2023, Read More

Huber, H., Blennow, K., Zetterberg, H., Boada, M., Jeromin, A., Weninger, H., Nuñez-Llaves, R., Aguilera, N., Ramis, M., Simrén, J., Nilsson, J., Lantero-Rodriguez, J., Orellana, A., García-Gutiérrez, F., Morató, X., Ashton, N. J., & Montoliu-Gaya, L. Biomarkers of Alzheimer’s disease and neurodegeneration in dried blood spots-A new collection method for remote settings, Alzheimer's & Dementia, January 29, 2024, Read More

Gobom, J., Brinkmalm, A., Brinkmalm, G., Blennow, K., & Zetterberg, H. Alzheimer’s disease biomarker analysis using targeted mass spectrometry, Molecular & Cellular Proteomics, January 20, 2024, Read More

Brum, W. S., Docherty, K. F., Ashton, N. J., Zetterberg, H., Hansson, O., McMurray, J. J. V., & Blennow, K. Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial, JAMA Neurology, December 18, 2023, Read More

Neumann, A., Ohlei, O., Küçükali, F., Bos, I. J., Timsina, J., Vos, S., Prokopenko, D., Tijms, B. M., Andreasson, U., Blennow, K., Vandenberghe, R., Scheltens, P., Teunissen, C. E., Engelborghs, S., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Lleó, A., Alcolea, D., … EMIF-AD & ADNI study group Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning, Genome Medicine, October 4, 2023, Read More